Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Brinkmann

Showing results (21-30 of 97) with videos related to

Pageof 10
Sort By:
Cancer Genomics & Proteomics|November 20, 2012
Genetically engineered fusion proteins for treatment of cancerUlrich H Weidle, Britta Schneider, Guy Georges, et al.
Cancer Genomics & Proteomics|December 28, 2018
The Functional Role of Prostate Cancer Metastasis-related Micro-RNAsUlrich H Weidle, Alexandra Epp, Fabian Birzele, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 17, 2015
Hapten-Binding Bispecific Antibodies for the Targeted Delivery of SiRNA and SiRNA-Containing NanoparticlesIrmgard S Thorey, Michael Grote, Klaus Mayer, et al.
Mabs|August 21, 2010
Fluorescent Citrine-IgG fusion proteins produced in mammalian cellsAlexander K Haas, Christoffer von Schwerin, Daniela Matscheko, et al.
Nature Reviews. Drug Discovery|March 6, 2024
The present and future of bispecific antibodies for cancer therapyChristian Klein, Ulrich Brinkmann, Janice M Reichert, et al.
Expert Opinion on Biological Therapy|April 23, 2004
Development of secreted proteins as biotherapeutic agentsAngelika L Bonin-Debs, Irene Boche, Hendrik Gille, et al.
Biomolecules|April 27, 2024
Functional Integrity of Radical SAM Enzyme Dph1•Dph2 Requires Non-Canonical Cofactor Motifs with Tandem CysteinesKoray Ütkür, Klaus Mayer, Shihui Liu, et al.
Toxins|March 2, 2017
Influence of DPH1 and DPH5 Protein Variants on the Synthesis of Diphthamide, the Target of ADPRibosylating ToxinsKlaus Mayer, Anna Schröder, Jerome Schnitger, et al.
FEBS Letters|January 18, 2025
Diphthamide synthesis is linked to the eEF2-client chaperone machineryLars Kaduhr, Klaus Mayer, Raffael Schaffrath, et al.
Cancer Genomics & Proteomics|July 30, 2013
The emerging role of new protein scaffold-based agents for treatment of cancerUlrich H Weidle, Johannes Auer, Ulrich Brinkmann, et al.
Pageof 10

Showing results (21-30 of 97) with videos related to

Sort By:
Pageof 10
Cancer Genomics & Proteomics|November 20, 2012
Genetically engineered fusion proteins for treatment of cancerUlrich H Weidle, Britta Schneider, Guy Georges, et al.
Cancer Genomics & Proteomics|December 28, 2018
The Functional Role of Prostate Cancer Metastasis-related Micro-RNAsUlrich H Weidle, Alexandra Epp, Fabian Birzele, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 17, 2015
Hapten-Binding Bispecific Antibodies for the Targeted Delivery of SiRNA and SiRNA-Containing NanoparticlesIrmgard S Thorey, Michael Grote, Klaus Mayer, et al.
Mabs|August 21, 2010
Fluorescent Citrine-IgG fusion proteins produced in mammalian cellsAlexander K Haas, Christoffer von Schwerin, Daniela Matscheko, et al.
Nature Reviews. Drug Discovery|March 6, 2024
The present and future of bispecific antibodies for cancer therapyChristian Klein, Ulrich Brinkmann, Janice M Reichert, et al.
Expert Opinion on Biological Therapy|April 23, 2004
Development of secreted proteins as biotherapeutic agentsAngelika L Bonin-Debs, Irene Boche, Hendrik Gille, et al.
Biomolecules|April 27, 2024
Functional Integrity of Radical SAM Enzyme Dph1•Dph2 Requires Non-Canonical Cofactor Motifs with Tandem CysteinesKoray Ütkür, Klaus Mayer, Shihui Liu, et al.
Toxins|March 2, 2017
Influence of DPH1 and DPH5 Protein Variants on the Synthesis of Diphthamide, the Target of ADPRibosylating ToxinsKlaus Mayer, Anna Schröder, Jerome Schnitger, et al.
FEBS Letters|January 18, 2025
Diphthamide synthesis is linked to the eEF2-client chaperone machineryLars Kaduhr, Klaus Mayer, Raffael Schaffrath, et al.
Cancer Genomics & Proteomics|July 30, 2013
The emerging role of new protein scaffold-based agents for treatment of cancerUlrich H Weidle, Johannes Auer, Ulrich Brinkmann, et al.
Pageof 10